| Literature DB >> 32089672 |
Babatunde M Duduyemi1,2, Abidemi E Omonisi3, Nicholas A Titiloye1.
Abstract
Introduction. Skin and soft tissue diseases form a large and heterogeneous group of mesenchymal extraskeletal and dermatologic lesions in humans. Diseases of the skin and soft tissue can develop virtually anywhere in the body, extremities, the trunk, the retroperitoneum, the head, and the neck. Our study aims to review skin and soft tissue specimens from our centre describing the histopathological patterns.Entities:
Year: 2019 PMID: 32089672 PMCID: PMC7012205 DOI: 10.1155/2019/8143680
Source DB: PubMed Journal: Dermatol Res Pract ISSN: 1687-6113
General characteristics of our patients by gender and age.
| Ages | Gender (%) | ||
|---|---|---|---|
| Male | Female | Total | |
| 0–9 | 13 (6.5) | 19 (7.6) | 32 (7.1) |
| 10–19 | 24 (11.9) | 26 (10.4) | 50 (11.1) |
| 20–29 | 31 (15.4) | 55 (22.0) | 86 (19.1) |
| 30–39 | 54 (26.9) | 81 (32.4) | 135 (29.9) |
| 40–49 | 47 (23.4) | 44 (17.6) | 91 (20.2) |
| 50–59 | 23 (11.4) | 14 (5.6) | 37 (8.2) |
| 60–69 | 6 (3.0) | 8 (3.2) | 14 (3.1) |
| 70–79 | 1 (0.5) | 1 (0.4) | 2 (0.4) |
| 80–89 | 2 (1.0) | 2 (0.8) | 4 (0.9) |
| Total | 201 | 250 | 451 (100) |
Figure 1Frequency distribution of the lesions with site.
Relationship between the gender and site of the lesion.
| Gender | Sites (%) | ||||||
|---|---|---|---|---|---|---|---|
| Upper limb | Lower limb | Perineal | Trunk | Neck | Head | Total, | |
| Male | 40 (19.9) | 57 (28.4) | 9 (4.5) | 31 (15.9) | 6 (3.0) | 57 (28.4) | 201 (44.6) |
| Female | 81 (32.4) | 51 (20.4) | 15 (6.0) | 42 (16.8) | 18 (7.2) | 43 (17.2) | 250 (53.4) |
| Total | 121 (26.8) | 108 (23.9) | 24 (5.3) | 74 (16.4) | 24 (5.3) | 100 (22.2) | 451 (100) |
Relationship between the ages and site of the lesion.
| Ages | Sites (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Upper limb | Lower limb | Perinea l | Trunk | Neck | Head | Total |
| |
| 0–9 | 9 (28.1) | 8 (25.0) | 2 (6.2) | 1 (3.1) | 6 (18.8) | 6 (18.8) | 32 (100) | 0.346 |
| 10–19 | 12 (24.0) | 11 (22.0) | 2 (4.0) | 9 (18.0) | 2 (4.0) | 14 (28.0) | 50 (100) | |
| 20–29 | 18 (20.9) | 22 (25.6) | 5 (5.8) | 13 (15.1) | 2 (2.3) | 26 (30.2) | 86 (100) | |
| 30–39 | 41 (30.4) | 25 (18.5) | 12 (8.9) | 25 (18.5) | 7 (5.2) | 25 (18.5) | 135 (100) | |
| 40–49 | 26 (28.6) | 27 (29.7) | 2 (2.2) | 17 (18.7) | 4 (4.4) | 15 (16.5) | 91 (100) | |
| 50–59 | 10 (27.0) | 11 (29.7) | 1 (2.7) | 6 (16.2) | 1 (2.7) | 8 (21.6) | 37 (100) | |
| 60–69 | 4 (28.6) | 3 (21.4) | 0 (0.0) | 2 (14.3) | 2 (14.3) | 3 (21.4) | 14 (100) | |
| 70–79 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (50.0) | 0 (50.0) | 1 (50.0) | 2 (100) | |
| 80–89 | 1 (25.0) | 1 (25.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (50.0) | 4 (100) | |
| Total | 121 (26.8) | 108 (23.9) | 24 (5.3) | 74 (16.4) | 24 (5.3) | 100 (22.2) | 451 (100) | |
Distribution and comparison of types of lesions with gender.
| Type of lesion | Male | Female | Frequency | Percentage (%) |
|---|---|---|---|---|
| Neoplastic | 132 (65.7) | 176 (70.4) | 308 | 68.3 |
| Inflammatory | 40 (19.9) | 36 (14.4) | 76 | 16.9 |
| Cyst | 26 (12.9) | 33 (13.2) | 59 | 13.1 |
| Reactive | 3 (1.5) | 4 (1.6) | 7 | 1.6 |
| Growth disorder | 0 (0.0) | 1 (0.4) | 1 | 0.2 |
| Total | 201 (100) | 250 (100) | 451 | 100 |
Figure 2Frequency distribution of neoplastic lesions in our patients.
Frequency distribution of benign and malignant neoplasms.
| Benign | Malignant | ||||||
|---|---|---|---|---|---|---|---|
| Types | Male | Female | Total | Types | Male | Female | Total |
| Lipoma | 51 (17.48%) | 95 (33.57%) |
| Embryonal rhabdomyosarcoma | 1 (4.55%) | 0 (0%) |
|
| Lymphagioma | 3 (1.05%) | 0 (0%) |
| Peripheral nerve sheath tumour | 1 (4.55%) | 0 (0%) |
|
| Dermatofibroma | 4 (1.39%) | 11 (3.85%) |
| Dermatofibrosarcoma | |||
| Protuberous | 1 (4.55%) | 1 (4.55%) |
| ||||
| Neurofibroma | 6 (2.10%) | 7 (2.45%) |
| Fibrosarcoma | 1 (4.55%) | 0 (0%) |
|
| Nevus | 3 (1.05%) | 6 (2.10%) |
| Kaposi sarcoma | 1 (4.55%) | 2 (9.10%) |
|
| Squamous papilloma | 10 (3.50%) | 18 (6.29%) |
| Squamous cell carcinoma | 2 (9.10%) | 3 (13.64%) |
|
| Capillary haemangioma | 15 (5.24%) | 10 (3.50%) |
| Basal cell carcinoma | 2 (9.10%) | 3 (13.64%) |
|
| Nodular tenosynovitis | 5 (1.75%) | 7 (2.45%) |
| Osteosarcoma | 1 (4.55%) | 0 (0%) |
|
| Verruca vulgaris | 14 (4.90%) | 8 (2.80%) |
| Melanoma | 1 (4.55%) | 1 (4.55%) |
|
| Oncocytoma | 1 (0.35%) | 0 (0%) |
| Pleomorphic sarcoma | 1 (4.55%) | 0 (0%) |
|
| Eccrine spiradenoma | 3 (1.05%) | 3 (1.05%) |
|
|
|
|
|
| Desmoid tumour | 1 (0.35%) | 0 (0%) |
| ||||
| Schwannoma | 4 (1.49%) | 1 (0.35%) |
| ||||
|
|
|
|
| ||||